PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
Rhea-AI Summary
PetMed Express (Nasdaq:PETS), doing business as PetMeds and parent of PetCareRx, will report Q4 and fiscal year 2026 results for the period ended March 31, 2026, on Tuesday, June 2, 2026 after market close.
A conference call and webcast follow at 4:30 PM ET.
Positive
- None.
Negative
- None.
News Market Reaction – PETS
In the May 29 session, PETS declined 1.36%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 22 | Strategic partnership | Positive | -3.9% | Announced Rural King white-label pet pharmacy across retail and digital channels. |
| Dec 16 | Acquisition proposal | Positive | +35.9% | Unsolicited all-cash proposal at $4.25 per share implying $89M equity value. |
| Dec 11 | Acquisition proposal | Positive | +68.4% | Unsolicited non-binding $4.00 per share cash proposal from SilverCape Investments. |
| Dec 10 | Product launch | Positive | +9.9% | Launch of 2025 wellness-focused holiday collection for pets and pet parents. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Takeover-related and product news have often seen positive price alignment, while a recent strategic partnership drew a negative reaction.
Recent news for PETS has centered on strategic and corporate actions. A Dec 10, 2025 wellness-focused holiday collection announcement saw a +9.94% reaction. Two unsolicited all-cash acquisition proposals at $4.00–$4.25 per share in Dec 2025 produced sharp gains of +68.36% and +35.89%. By contrast, an Apr 22, 2026 strategic partnership with Rural King coincided with a -3.88% move, indicating the market has not uniformly rewarded strategic initiatives.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day.
Date: Tuesday, June 2, 2026
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: 4Q Earnings Webcast
A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through June 16, 2026.
Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13760873
About PetMed Express, Inc.
Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PETS family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.
Investor Contact:
ICR, LLC
Reed Anderson
(646) 277-1260
investor@petmeds.com
